Cargando…
Lipid-Based Drug Delivery Nanoplatforms for Colorectal Cancer Therapy
Colorectal cancer (CRC) is a prevalent disease worldwide, and patients at late stages of CRC often suffer from a high mortality rate after surgery. Adjuvant chemotherapeutics (ACs) have been extensively developed to improve the survival rate of such patients, but conventionally formulated ACs inevit...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7408503/ https://www.ncbi.nlm.nih.gov/pubmed/32708193 http://dx.doi.org/10.3390/nano10071424 |